Pulse Biosciences (Nasdaq:PLSE) today announced new positive clinical findings for its nPulse cardiac catheter system.
IDE supplement expands trial to the other primary standard-of-care chemotherapy for pancreatic cancer patients, alongside ...
Hosted on MSN
Level up your Pascal skills through real projects
Pascal remains a strong choice for learning structured programming and tackling coding challenges that build practical problem-solving skills. While tutorials offer the basics, applying Pascal to ...
Developers are rethinking AI-assisted coding workflows, with some moving away from expensive, fully agentic tools like Claude Code in favor of hybrid editors such as Zed. Zed blends traditional, hands ...
Medtronic plc, , a global leader in healthcare technology, today announced continued momentum for the Afferatm family of technologies for cardiac arrhythmia treatment, including promising data ...
CMS & US FDA announce RAPID coverage pathway to accelerate patient access to life-changing medical devices: Maryland Saturday, April 25, 2026, 11:00 Hrs [IST] The Centers for Medi ...
These 11 AI tools for conducting interviews will help recruiters and HR teams quickly and efficiently select the best ...
Medtronic (NYSE:MDT) today announced new milestones for its Affera family of technologies, including FDA breakthrough device ...
FDA expands Alpha DaRT IMPACT trial to 40 patients, adding gemcitabine and nab-paclitaxel cohort in pancreatic cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results